Actively Recruiting
Adaptation and Implementation of an Evidence-based Approach to Advance HIV Prevention and Care
Led by University of California, Los Angeles ยท Updated on 2026-04-21
80
Participants Needed
1
Research Sites
14 weeks
Total Duration
On this page
Sponsors
U
University of California, Los Angeles
Lead Sponsor
U
University of Medicine and Pharmacy at Ho Chi Minh City
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating an evidence-based approach called TransAction to support HIV prevention and care among transgender women. This study will compare two groups: one receiving the full TransAction program including individual risk reduction sessions, skill-building, open group support, and social events, and a control group invited only to social events. The study aims to measure progress in HIV prevention and care, sexual risk behaviors, substance use, social support, stigma, well-being, and quality of life over six months. Participants in the intervention group will engage in sessions focused on reducing HIV risk behaviors, promoting regular HIV testing and treatment adherence, and strengthening family and social support within three months after baseline. Both groups will be invited to two social events designed to share health information and build social connections in a festive setting. The study uses a randomized design without masking. Throughout the study, participants will be assessed at baseline, three months, and six months for their placement on the HIV prevention and care continuum. Researchers will also evaluate self-efficacy, social support, general well-being, and quality of life. Implementation outcomes such as feasibility, acceptability, and sustainability will be studied through documentation, investigator evaluations, and feedback from participants and facilitators. The total participation includes follow-ups over six months.
CONDITIONS
Brief Title
Adaptation and Implementation of an Evidence-based Approach to Advance HIV Prevention and Care
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 16 years of age or older
- Assigned male at birth and currently self-identified as a transgender woman
- Currently living in Ho Chi Minh City adjacent areas with no plans to move in the next 6 months
- Able to participate in study activities as judged by the study recruiter
You will not qualify if you...
- Previously involved in intervention adaptation activities with the study team
- Unable to give informed consent or assent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 3 months
Participants in the intervention condition attend individual risk reduction sessions, skill building, and group support sessions focused on reducing HIV risk behaviors, testing, medication adherence, and social support. Participants in both intervention and control conditions are invited to social events to share health information and foster social support.
Baseline visit, plus sessions and social events between baseline and 3 months
Duration - 3 months
Participants complete assessments to evaluate outcomes such as HIV prevention/care progress, self-efficacy, social support, well-being, and quality of life.
Visits at 3-month and 6-month follow-ups
Trial Site Locations
Total: 1 location
1
University of Medicine and Pharmacy
Ho Chi Minh City, Vietnam
Actively Recruiting
Research Team
C
Chunqing Lin, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here